Morgan Stanley’s Predictive Oncology POAI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,800
| Closed | -$2K | – | 7929 |
|
|
2022
Q1 | $2K | Buy |
2,800
+297
| +12% | +$212 | ﹤0.01% | 7753 |
|
|
2021
Q4 | $2K | Buy |
2,503
+3
| +0.1% | +$2 | ﹤0.01% | 7804 |
|
|
2021
Q3 | $3K | Hold |
2,500
| – | – | ﹤0.01% | 7606 |
|
|
2021
Q2 | $3K | Buy |
+2,500
| New | +$3K | ﹤0.01% | 7491 |
|
|
2019
Q4 | – | Sell |
-625
| Closed | – | – | 6735 |
|
|
2019
Q3 | $0 | Hold |
625
| – | – | ﹤0.01% | 6723 |
|
|
2019
Q2 | $0 | Buy |
625
+2
| +0.3% | – | ﹤0.01% | 6714 |
|
|
2019
Q1 | $0 | Buy |
623
+9
| +1% | – | ﹤0.01% | 6677 |
|
|
2018
Q4 | $0 | Buy |
614
+81
| +15% | – | ﹤0.01% | 6696 |
|
|
2018
Q3 | $1K | Sell |
533
-90
| -14% | -$169 | ﹤0.01% | 6639 |
|
|
2018
Q2 | $1K | Hold |
623
| – | – | ﹤0.01% | 6602 |
|
|
2018
Q1 | $1K | Hold |
623
| – | – | ﹤0.01% | 6551 |
|
|
2017
Q4 | $1K | Buy |
623
+2
| +0.3% | +$3 | ﹤0.01% | 6498 |
|
|
2017
Q3 | $1K | Sell |
621
-38
| -6% | -$61 | ﹤0.01% | 6459 |
|
|
2017
Q2 | $1K | Sell |
659
-17,288
| -96% | -$26.2K | ﹤0.01% | 6515 |
|
|
2017
Q1 | $38K | Sell |
17,947
-59,939
| -77% | -$127K | ﹤0.01% | 5915 |
|
|
2016
Q4 | $218K | Buy |
77,886
+77,406
| +16,126% | +$217K | ﹤0.01% | 5318 |
|
|
2016
Q3 | $0 | Sell |
480
-72
| -13% | – | ﹤0.01% | 6547 |
|
|
2016
Q2 | $0 | Sell |
552
-937
| -63% | – | ﹤0.01% | 6616 |
|
|
2016
Q1 | $0 | Buy |
1,489
+1,480
| +16,444% | – | ﹤0.01% | 6672 |
|
|
2015
Q4 | $0 | Sell |
9
-3,491
| -100% | – | ﹤0.01% | 6754 |
|
|
2015
Q3 | $11K | Buy |
+3,500
| New | +$11K | ﹤0.01% | 6211 |
|